Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597912 | SCV000702721 | uncertain significance | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000597912 | SCV002541101 | uncertain significance | not provided | 2021-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000597912 | SCV003252804 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000597912 | SCV005190987 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003980079 | SCV004790333 | likely benign | ABCC2-related disorder | 2021-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |